The blood-brain barrier: An engineering perspective

Frontiers in Neuroengineering

Volumn , Issue JUL, 2013, Pages

  Wong, Andrew D ^a   Ye, Mao ^a   Levy, Amanda F ^a   Rothstein, Jeffrey D ^b,c   Bergles, Dwight E ^b   Searson, Peter C ^a  

^a Johns Hopkins University   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Blood brain barrier; Capillary; Microvasculature; Neurovascular unit; Transport

Indexed keywords

CLAUDIN; HYALURONIC ACID;

ACTIVE TRANSPORT; ASTROCYTE; BASEMENT MEMBRANE; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; BRAIN CAPILLARY; BRAIN SIZE; CELL JUNCTION; CENTRAL NERVOUS SYSTEM DISEASE; ELECTRIC RESISTANCE; EXTRACELLULAR MATRIX; EXTRACELLULAR SPACE; HOMEOSTASIS; HUMAN; INTERNAL CAROTID ARTERY; LIPOPHILICITY; MEMBRANE TRANSPORT; MICROVASCULAR ENDOTHELIAL CELL; NONHUMAN; PASSIVE TRANSPORT; PERICYTE; REVIEW; SHEAR STRESS; TIGHT JUNCTION; TRANSCYTOSIS; TRANSENDOTHELIAL ELECTRICAL RESISTANCE; VERTEBRAL ARTERY;

EID: 84883400046     PISSN: 16626443     EISSN: None     Source Type: Journal    
DOI: 10.3389/fneng.2013.00007     Document Type: Review

References (276)

1. Abbott, N. J. (2002). Astrocyte-endothelial interactions and blood-brain barrier permeability. J. Anat. 200, 629-638. doi: 10.1046/j.1469-7580.2002.00064.x
2. Abbott, N. J., Patabendige, A. A., Dolman, D. E., Yusof, S. R., and Begley, D. J. (2010). Structure and function of the blood-brain barrier. Neurobiol. Dis. 37, 13-25. doi: 10.1016/j.nbd.2009.07.030
3. Abbott, N. J., Ronnback, L., and Hansson, E. (2006). Astrocyte- endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 7, 41-53. doi: 10.1038/nrn1824
4. Adson, A., Raub, T. J., Burton, P. S., Barsuhn, C. L., Hilgers, A. R., Audus, K. L., et al. (1994). Quantitative approaches to delineate paracellular diffusion in cultured epithelial cell monolayers. J. Pharm. Sci. 83, 1529-1536. doi: 10.1002/jps.26008 31103
5. Aiello, L. C., and Dunbar, R. I. M. (1993). Neocortex size, group-size, and the evolution of language. Curr. Anthropol. 34, 184-193. doi: 10.1086/204160
6. Aiello, L. C., and Wheeler, P. (1995). The expensive-tissue hypothesis - the brain and the digestive-system in human and primate evolution. Curr. Anthropol. 36, 199-221. doi: 10.1086/204350
7. Aird, W. C. (2005). Spatial and temporal dynamics of the endothelium. J. Thromb. Haemost. 3, 1392-1406. doi: 10.1111/j.1538-7836.2005.01328.x
8. Aird, W. C. (2007). Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ. Res. 100, 158-173. doi: 10.1161/01.RES.0000255691. 76142.4a
9. Ananthanarayanan, B., Kim, Y., and Kumar, S. (2011). Elucidating the mechanobiol-ogy of malignant brain tumors using a brain matrix-mimetic hyaluronic acid hydrogel platform. Biomaterials 32, 7913-7923. doi: 10.1016/j.biomaterials.2011.07.005
10. Armulik, A., Abramsson, A., and Betsholtz, C. (2005). Endothelial/pericyte interactions. Circ. Res. 97, 512-523. doi: 10. 1161/01.RES.0000182903.16652.d7
11. Armulik, A., Genove, G., Mae, M., Nisancioglu, M. H., Wallgard, E., Niaudet, C., et al. (2010). Pericytes regulate the blood-brain barrier. Nature 468, 557-561. doi: 10.1038/nature09522
12. Artursson, P. (1991). Cell-cultures as models for drug absorption across the intestinal-mucosa. Crit. Rev. Ther. Drug Carrier Syst. 8, 305-330.
13. Artursson, P., Palm, K., and Luthman, K. (2001). Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv. Drug Deliv. Rev. 46, 27-43. doi: 10.1016/S0169-409X(00)00128-9
14. Asahara, T., Kawamoto, A., and Masuda, H. (2011). Concise review: circulating endothelial progenitor cells for vascular medicine. Stem Cells 29, 1650-1655. doi: 10.1002/stem.745
15. Attwell, D., Buchan, A. M., Charpak, S., Lauritzen, M., Macvicar, B. A., and Newman, E. A. (2010). Glial and neuronal control of brain blood flow. Nature 468, 232-243. doi: 10.1038/nature09613
16. Attwell, D., and Laughlin, S. B. (2001). An energy budget for signaling in the grey matter of the brain. J. Cereb. Blood Flow Metab. 21, 1133-1145. doi: 10.1097/00004647-200110000-00001
17. Audus, K. L., and Borchardt, R. T. (1986). Characteristics of the large neutral amino acid transport system of bovine brain microvessel endothelial cell monolayers. J. Neurochem. 47, 484-488. doi: 10.1111/j.1471-4159.1986.tb04527.x
18. Aumailley, M., Bruckner-Tuderman, L., Carter, W. G., Deutzmann, R., Edgar, D., Ekblom, P., et al. (2005) A simplified laminin nomenclature. Matrix Biol. 24, 326-332. doi: 10.1016/j.matbio.2005.05.006
19. Avdeef, A. (2001). Physicochemical profiling (solubility, permeability and charge state). Curr. Top. Med. Chem. 1, 277-351. doi: 10.2174/1568026013395100
20. Avdeef, A. (2003). Absorption and Drug Development: Solubility, Permeability, and Charge State. Hoboken, NJ: Wiley. doi: 10.1002/047145026X
21. Avdeef, A., Artursson, P., Neuhoff, S., Lazorova, L., Gråsjö, J., and Tavelin, S. (2005). Caco-2 permeability of weakly basic drugs predicted with the Double-Sink PAMPA method. Eur. J. Pharm. Sci. 24, 333-349. doi: 10.1016/j.ejps.2004.11.011
22. Balimane, P. V., Han, Y. H., and Chong, S. H. (2006). Current industrial practices of assessing permeability and P-glycoprotein interaction. AAPS J. 8, E1-E13. doi: 10.1208/aapsj080101
23. Barry, P. H., and Diamond, J. M. (1984). Effects of unstirred layers on membrane phenomena. Physiol. Rev. 64, 763-872.
24. Bartels, A. L., Willemsen, A. T., Kortekaas, R., De Jong, B. M., De Vries, R., De Klerk, O., et al. (2008). Decreased blood-brain barrier P-glycoprotein function in the progression of Parkinson's disease, PSP and MSA. J. Neural Transm. 115, 1001-1009. doi: 10.1007/s00702-008-0030-y
25. Bauer, B., Hartz, A. M., Lucking, J. R., Yang, X., Pollack, G. M., and Miller, D. S. (2008). Coordinated nuclear receptor regulation of the efflux transporter, Mrp2, and the phase-II metabolizing enzyme, GSTpi, at the blood-brain barrier. J. Cereb. Blood Flow Metab. 28, 1222-1234. doi: 10.1038/jcbfm.2008.16
26. Bauer, B., Hartz, A. M., and Miller, D. S. (2007). Tumor necrosis factor alpha and endothelin-1 increase P-glycoprotein expression and transport activity at the blood-brain barrier. Mol. Pharmacol. 71, 667-675. doi: 10.1124/mol.106.029512
27. Bauer, B., Hartz, A. M. S., Fricker, G., and Miller, D. S. (2005). Modulation of p-glycoprotein transport function at the blood-brain barrier. Exp. Biol. Med. 230, 118-127.
28. Bazzoni, G., and Dejana, E. (2004). Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. Physiol. Rev. 84, 869-901. doi: 10.1152/phys-rev.00035.2003
29. Begley, D. J., and Brightman, M. W. (2003). "Structural and functional aspects of the blood brain barrier," in Progress in Drug Research, eds L. Prokai and K. Prokai-Tatrai (Basel:Birkhauser Verlag), 39-78.
30. Belayev, L., Busto, R., Zhao, W., and Ginsberg, M. D. (1996). Quantitative evaluation of blood-brain barrier permeability following middle cerebral artery occlusion in rats. Brain Res. 739, 88-96. doi: 10.1016/S0006-8993 (96)00815-3
31. Bell, R. D., Winkler, E. A., Sagare, A. P., Singh, I., Larue, B., Deane, R., et al. (2010). Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. Neuron 68, 409-427. doi: 10.1016/j.neuron.2010.09.043
32. Benarroch, E. E. (2011). Circumventricular organs: receptive and homeostatic functions and clinical implications. Neurology 77, 1198-1204. doi:10.1212/WNL.0b013e31822f04a0
33. Berger, J. R., and Avison, M. (2004). The blood brain barrier in HIV infection. Front. Biosci. 9, 2680-2685. doi: 10.2741/1427
34. Bernas, M. J., Cardoso, F. L., Daley, S. K., Weinand, M. E., Campos, A. R., Ferreira, A. J. G., et al. (2010). Establishment of primary cultures of human brain microvascular endothelial cells to provide an in vitro cellular model of the blood-brain barrier. Nat. Protoc. 5, 1265-1272. doi: 10.1038/nprot.2010.76
35. Boero, J. A., Ascher, J., Arregui, A., Rovainen, C., and Woolsey, T. A. (1999). Increased brain capillaries in chronic hypoxia. J. Appl. Physiol. 86, 1211-1219.
36. Bonkowski, D., Katyshev, V., Balabanov, R. D., Borisov, A., and Dore-Duffy, P. (2011). The CNS microvascular pericyte: pericyte-astrocyte crosstalk in the regulation of tissue survival. Fluids Barriers CNS 8, 8. doi: 10.1186/2045-8118-8-8
37. Borowsky, I. W., and Collins, R. C. (1989a). Metabolic anatomy of brain - a comparison of regional capillary density, glucose-metabolism, and enzyme-activities. J. Comp. Neurol. 288, 401-413. doi: 10.1002/cne.902880304
38. Borowsky, I. W., and Collins, R. C. (1989b). Metabolic anatomy of brain: a comparison of regional capillary density, glucose metabolism, and enzyme activities. J. Comp. Neurol. 288, 401-413. doi: 10.1002/cne.902880304
39. Bostrom, E., Hammarlund-Udenaes, M., and Simonsson, U. S. (2008). Blood-brain barrier transport helps to explain discrepancies in in vivo potency between oxycodone and morphine. Anesthesiology 108, 495-505. doi: 10.1097/ALN.0b013e318164cf9e
40. Bouw, M. R., Gardmark, M., and Hammarlund-Udenaes, M. (2000). Pharmacokinetic-pharmacodynamic modelling of morphine transport across the blood-brain barrier as a cause of the antinociceptive effect delay in rats - a microdialysis study. Pharm. Res. 17, 1220-1227. doi: 10.1023/A:1026414713509
41. Bowman, P. D., Ennis, S. R., Rarey, K. E., Lorris Betz, A., and Goldstein, G. W. (1983). Brain microves-sel endothelial cells in tissue culture: a model for study of blood-brain barrier permeability. Ann. Neurol. 14, 396-402. doi: 10.1002/ana.410140403
42. Bradbury, M. W. (1993). The blood-brain barrier. Exp. Physiol. 78, 453-472.
43. Brightman, M. W. (1977). Morphology of blood-brain interfaces. Exp. Eye Res. 25, 1-25. doi: 10.1016/S0014-4835(77)80008-0
44. Bronger, H., Konig, J., Kopplow, K., Steiner, H. H., Ahmadi, R., Herold-Mende, C., et al. (2005). ABCC drug efflux pumps and organic anion uptake transporters in human gliomas and the blood-tumor barrier. Cancer Res. 65, 11419-11428. doi: 10.1158/0008-5472.CAN-05-1271
45. Butt, A. M., and Jones, H. C. (1992). Effect of histamine and antagonists on electrical-resistance across the blood-brain-barrier in rat brain-surface microvessels. Brain Res. 569, 100-105. doi: 10.1016/0006-8993(92)90374-I
46. Campos, C. R., Schroter, C., Wang, X., and Miller, D. S. (2012). ABC transporter function and regulation at the blood-spinal cord barrier. J. Cereb. Blood Flow Metab. 32, 1559-1566. doi: 10.1038/jcbfm.2012.47
47. Cannon, R. E., Peart, J. C., Hawkins, B. T., Campos, C. R., and Miller, D. S. (2012). Targeting blood-brain barrier sphingolipid signaling reduces basal P-glycoprotein activity and improves drug delivery to the brain. Proc. Natl. Acad. Sci. U.S.A. 109, 15930-15935. doi: 10.1073/pnas.1203534109
48. Caplan, B. A., Gerrity, R. G., and Schwartz, C. J. (1974). Endothelial cell morphology in focal areas of in vivo Evans blue uptake in the young pig aorta. I. Quantitative light microscopic findings. Exp. Mol. Pathol. 21, 102-117. doi: 10.1016/0014-4800(74)90082-3
49. Cecchelli, R., Berezowski, V., Lundquist, S., Culot, M., Renftel, M., Dehouck, M. P., et al. (2007). Modelling of the blood-brain barrier in drug discovery and development. Nat. Rev. Drug Discov. 6, 650-661. doi: 10.1038/ nrd2368
50. Cecchelli, R., Dehouck, B., Descamps, L., Fenart, L., Buée-Scherrer, V., Duhem, C., et al. (1999). In vitro model for evaluating drug transport across the blood-brain barrier. Adv. Drug Deliv. Rev. 36, 165-178. doi: 10.1016/S0169-409X(98)00083-0
51. Chappa, A., Audus, K., and Lunte, S. (2006). Characteristics of substance p transport across the blood-brain barrier. Pharm. Res. 23, 1201-1208. doi: 10.1007/s11095-006-0068-1
52. Chien, S. (2007). Mechanotransduction and endothelial cell home-ostasis: the wisdom of the cell. Am. J. Physiol. Heart Circ. Physiol. 292, H1209-H1224. doi: 10.1152/ajpheart.01047.2006
53. Chishty, M., Reichel, A., Siva, J., Abbott, N. J., and Begley, D. J. (2001). Affinity for the P-glycoprotein efflux pump at the blood-brain barrier may explain the lack of CNS side-effects of modern antihistamines. J. Drug Target. 9, 223-228. doi: 10.3109/10611860108997930
54. Conway, D., and Schwartz, M. A. (2012). Lessons from the endothe-lial junctional mechanosensory complex. F1000 Biol. Rep. 4, 1.
55. Crone, C. (1963). The permeability of capillaries in various organs as determined by use of the indicator diffusion method. Acta Physiol. Scand. 58, 292-305. doi: 10.1111/j.1748-1716.1963.tb02652.x
56. Crone, C., and Olesen, S. P. (1982). Electrical resistance of brain microvascular endothelium. Brain Res. 241, 49-55. doi: 10.1016/0006-8993(82)91227-6
57. Cucullo, L., Hossain, M., Puvenna, V., Marchi, N., and Janigro, D. (2011). The role of shear stress in blood-brain barrier endothelial physiology. BMC Neurosci. 12:40. doi: 10.1186/1471-2202-12-40
58. Dalkara, T., Gursoy-Ozdemir, Y., and Yemisci, M. (2011). Brain microvas-cular pericytes in health and disease. Acta Neuropathol. 122, 1-9. doi: 10.1007/s00401-011-0847-6
59. Dallasta, L. M., Pisarov, L. A., Esplen, J. E., Werley, J. V., Moses, A. V., Nelson, J. A., et al. (1999). Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. Am. J. Pathol. 155, 1915-1927. doi: 10.1016/S0002-9440(10)65511-3
60. Daneman, R. (2012). The blood-brain barrier in health and disease. Ann. Neurol. 72, 648-672. doi:10.1002/ana.23648.
61. Daneman, R., Agalliu, D., Zhou, L., Kuhnert, F., Kuo, C. J., and Barres, A. (2009). Wnt/beta-catenin sig naling is required for CNS, but not non-CNS, angiogenesis. Proc. Natl. Acad. Sci. U.S.A. 106, 641-646. doi: 10.1073/pnas.0805165106
62. Daneman, R., Zhou, L., Kebede, A. A., and Barres, B. A. (2010). Pericytes are required for blood-brain barrier integrity during embryogen-esis. Nature 468, 562-566. doi: 10.1038/nature09513
63. Davies, D. C. (2002). Blood-brain barrier breakdown in septic encephalopathy and brain tumours. J. Anat. 200, 639-646. doi: 10.1046/j.1469-7580.2002.00065.x
64. Dawson, D. (1991). "Principles of membrane transport," in Handbook of Physiology, Section 6: The Gastrointestinal System, ed B. Rauner (Bethesda, MD: American Physiological Society), 1-45.
65. de Boer, A. G., and Gaillard, P. J. (2007). Drug targeting to the brain. Annu. Rev. Pharmacol. Toxicol. 47, 323-355. doi: 10.1146/annurev. pharmtox.47.120505.105237
66. de Boer, A. G., Van Der Sandt, I. J., and Gaillard, P. J. (2003). The role of drug transporters at the blood-brain barrier. Annu. Rev. Pharmacol. Toxicol. 43, 629-656. doi: 10.1146/annurev.pharmtox.43. 100901.140204
67. debault, L. E., and Cancilla, P. A. (1980). Gamma-glutamyl- transferase transpeptidase in isolated brain endothelial-cells - induction by glial-cells invitro. Science 207, 653-655. doi: 10.1126/science.6101511
68. Dejana, E. (2004). Endothelial cell-cell junctions: happy together. Nat. Rev. Mol. Cell Biol. 5, 261-270. doi: 10.1038/nrm1357
69. Del Zoppo, G. J. (2010). The neurovas-cular unit in the setting of stroke. J. Intern. Med. 267, 156-171. doi: 10.1111/j.1365-2796.2009.02199.x
70. Deli, M. A., Abraham, C. S., Kataoka, Y., and Niwa, M. (2005). Permeability studies on in vitro blood-brain barrier models: physiology, pathology, and pharmacology. Cell. Mol. Neurobiol. 25, 59-127. doi: 10.1007/s10571-004-1377-8
71. Demeule, M., Regina, A., Jodoin, J., Laplante, A., Dagenais, C., Berthelet, F., et al. (2002). Drug transport to the brain: key roles for the efflux pump P-glycoprotein in the blood-brain barrier. Vascul.Pharmacol. 38, 339-348. doi: 10.1016/S1537-1891(02)00201-X
72. Desai, B. S., Monahan, A. J., Carvey, P. M., and Hendey, B. (2007). Blood-brain barrier pathology in Alzheimer's and Parkinson's disease: implications for drug therapy. Cell Transplant. 16, 285-299.
73. Didier, A., Tiberghien, F., Wenger, R., and Loor, F. (1996). Detection of P-glycoprotein expression by tumoral cells with NBDL-CsA, a fluorescent derivative of cyclosporin A. Anticancer Drugs 7, 257-265. doi: 10.1097/00001813-199605000-00004
74. Dolan, J. M., Kolega, J., and Meng, H. (2013). High wall shear stress and spatial gradients in vascular pathology: a review. Ann. Biomed. Eng. 41, 1411-1427. doi: 10.1007/s10439-012-0695-0
75. Duvernoy, H., Delon, S., and Vannson, J. L. (1983). The vascularization of the human cerebellar cortex. Brain Res. Bull. 11, 419-480. doi: 10.1016/0361-9230(83)90116-8
76. Duvernoy, H. M., and Risold, P. Y. (2007). The circumventricular organs: an atlas of comparative anatomy and vascularization. Brain Res. Rev. 56, 119-147. doi: 10.1016/j.brainresrev.2007.06.002
77. Ekstrand, J., Hellsten, J., and Tingstrom, A. (2008). Environmental enrichment, exercise and corticosterone affect endothe-lial cell proliferation in adult rat hippocampus and prefrontal cortex. Neurosci. Lett. 442, 203-207. doi: 10.1016/j.neulet.2008.06.085
78. Enerson, B. E., and Drewes, L. R. (2006). The rat blood-brain barrier transcriptome. J. Cereb. Blood Flow Metab. 26, 959-973. doi: 10.1038/sj.jcbfm.9600249
79. Engelhardt, B. (2008a). The blood-central nervous system barriers actively control immune cell entry into the central nervous system. Curr. Pharm. Des. 14, 1555-1565. doi: 10.2174/138161208784705432
80. Engelhardt, B. (2008b). Immune cell entry into the central nervous system: involvement of adhesion molecules and chemokines. J. Neurol. Sci. 274, 23-26. doi: 10.1016/j.jns.2008.05.019
81. Fahraeus, R., and Lindqvist, T. (1931). The viscosity of the blood in narrow capillary tubes. Am. J. Physiol. 96, 562-568.
82. Farkas, E., and Luiten, P. G. M. (2001). Cerebral microvascular pathology in aging and Alzheimer's disease. Prog. Neurobiol. 64, 575-611. doi: 10.1016/S0301-0082(00)00068-X
83. Fenstermacher, J., Gross, P., Sposito, N., Acuff, V., Pettersen, S., and Gruber, K. (1988). Structural and functional variations in capillary systems within the brain. Ann. N.Y. Acad. Sci. 529, 21-30. doi: 10.1111/j.1749-6632.1988.tb51416.x
84. Fernandez-Klett, F., Offenhauser, N., Dirnagl, U., Priller, J., and Lindauer, U. (2010). Pericytes in capillaries are contractile in vivo, but arteri-oles mediate functional hyperemia in the mouse brain. Proc. Natl. Acad. Sci. U.S.A. 107, 22290-22295. doi: 10.1073/pnas.1011321108
85. Fiacco, T. A., Agulhon, C., and McCarthy, K. D. (2009). Sorting out astrocyte physiology from pharmacology. Annu. Rev. Pharmacol. Toxicol. 49, 151-174. doi: 10.1146/ annurev.pharmtox.011008.145602
86. Fish, J. L., and Lockwood, C. A. (2003). Dietary constraints on encephalization in primates. Am. J. Phys. Anthropol. 120, 171-181. doi: 10.1002/ajpa.10136
87. Fisher, M. (2009). Pericyte signaling in the neurovascular unit. Stroke 40, S13-S15. doi: 10.1161/STROKEAHA.108.533117
88. Franke, H., Galla, H.-J., and Beuckmann, C. T. (1999). An improved low-permeability in vitro-model of the blood-brain barrier: transport studies on retinoids, sucrose, haloperi-dol, caffeine and mannitol. Brain Res. 818, 65-71. doi: 10.1016/S0006-8993(98)01282-7
89. Freed, A. L., Audus, K. L., and Lunte, S. M. (2001). Investigation of the metabolism of substance P at the blood-brain barrier using capillary electrophoresis with laser-induced fluorescence detection. Electrophoresis 22, 3778-3784.
90. Freeman, M. R. (2010). Specification and morphogenesis of astro-cytes. Science 330, 774-778. doi: 10.1126/science.1190928
91. Friedman, A., Kaufer, D., Shemer, J., Hendler, I., Soreq, H., and Tur-Kaspa, I. (1996). Pyridostigmine brain penetration under stress enhances neuronal excitability and induces early immediate transcriptional response. Nat. Med. 2, 1382-1385. doi: 10.1038/nm1296-1382
92. Fujikawa, M., Nakao, K., Shimizu, R., and Akamatsu, M. (2007). QSAR study on permeability of hydrophobic compounds with artificial membranes. Bioorg. Med. Chem. 15, 3756-3767. doi: 10.1016/j.bmc.2007.03.040
93. Furuse, M., and Tsukita, S. (2006). Claudins in occluding junctions of humans and flies. Trends Cell Biol. 16, 181-188. doi: 10.1016/j.tcb.2006.02.006
94. Ganong, W. F. (2000). Circumventricular organs: definition and role in the regulation of endocrine and autonomic function. Clin. Exp. Pharmacol. Physiol. 27, 422-427. doi: 10.1046/j.1440-1681.2000.03259.x
95. Giacomini, K. M., Huang, S. M., Tweedie, D. J., Benet, L. Z., Brouwer, K. L., Chu, X., et al. (2010). Membrane transporters in drug development. Nat. Rev. Drug Discov. 9, 215-236. doi: 10.1038/nrd3028
96. Gold, R., Linington, C., and Lassmann, H. (2006). Understanding patho-genesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 129, 1953-1971. doi: 10.1093/brain/awl075
97. Gratton, J. A., Abraham, M. H., Bradbury, M. W., and Chadha, H. S. (1997). Molecular factors influencing drug transfer across the blood-brain barrier. J. Pharm. Pharmacol. 49, 1211-1216. doi: 10.1111/j.2042-7158.1997.tb06072.x
98. Gross, P. M., Sposito, N. M., Pettersen, S. E., and Fenstermacher, J. D. (1986). Differences in function and structure of the capillary endothe-lium in gray matter, white matter and a circumventricular organ of rat brain. Blood Vessels 23, 261-270.
99. Gumbleton, M., and Audus, K. L. (2001). Progress and limitations in the use of in vitro cell cultures to serve as a permeability screen for the blood-brain barrier. J. Pharm. Sci. 90, 1681-1698. doi: 10.1002/jps.1119
100. Hahn, C., and Schwartz, M. A. (2009). Mechanotransduction in vascular physiology and atherogenesis. Nat. Rev. Mol. Cell Biol. 10, 53-62. doi: 10.1038/nrm2596
101. Halassa, M. M., and Haydon, P. G. (2010). Integrated brain circuits: astrocytic networks modulate neu-ronal activity and behavior. Annu. Rev. Physiol. 72, 335-355. doi: 10.1146/annurev-physiol-021909-135843
102. Hamilton, N. B., Attwell, D., and Hall, C. N. (2010). Pericyte-mediated regulation of capillary diameter: a component of neurovascular coupling in health and disease. Front. Neuroenergetics 2:5. doi: 10.3389/fnene.2010.00005
103. Hammarlund-Udenaes, M., Bredberg, U., and Friden, M. (2009). Methodologies to assess brain drug delivery in lead optimization. Curr. Top. Med. Chem. 9, 148-162. doi: 10.2174/156802609787521607
104. Hammarlund-Udenaes, M., Friden, M., Syvanen, S., and Gupta, A. (2008). On the rate and extent of drug delivery to the brain. Pharm. Res. 25, 1737-1750. doi: 10.1007/s11095-007-9502-2
105. Hartmann, C., Zozulya, A., Wegener, J., and Galla, H. J. (2007). The impact of glia-derived extracellular matrices on the barrier function of cerebral endothelial cells: an in vitro study. Exp. Cell Res. 313, 1318-1325. doi: 10.1016/j.yexcr. 2007.01.024
106. Hartz, A. M., and Bauer, B. (2011). ABC transporters in the CNS - an inventory. Curr. Pharm. Biotechnol. 12, 656-673. doi: 10.2174/138920111795164020
107. Hartz, A. M., Miller, D. S., and Bauer, B. (2010). Restoring blood-brain barrier P-glycoprotein reduces brain amyloid-beta in a mouse model of Alzheimer's disease. Mol. Pharmacol. 77, 715-723. doi: 10.1124/mol.109.061754
108. Hartz, A. M. S., Bauer, B., Fricker, G., and Miller, D. S. (2004). Rapid regulation of p-glycoprotein at the blood-brain barrier by endothelin-1. Mol. Pharmacol. 66, 387-394. doi: 10.1124/mol.104.001503
109. Haseloff, R. F., Blasig, I. E., Bauer, H. C., and Bauer, H. (2005). In search of the astrocytic factor(s) modulating blood-brain barrier functions in brain capillary endothelial cells in vitro. Cell. Mol. Neurobiol. 25, 25-39. doi: 10.1007/s10571-004-1375-x
110. Hatherell, K., Couraud, P. O., Romero, I. A., Weksler, B., and Pilkington, G. J. (2011). Development of a three-dimensional, all- human in vitro model of the blood-brain barrier using mono-, co-, and tri-cultivation Transwell models. J. Neurosci. Methods 199, 223-229. doi: 10.1016/j.jneumeth.2011.05.012
111. Hauck, E. F., Apostel, S., Hoffmann, J. F., Heimann, A., and Kempski, O. (2004). Capillary flow and diameter changes during reperfusion after global cerebral ischemia studied by intravital video microscopy. J. Cereb. Blood Flow Metab. 24, 383-391. doi: 10.1097/00004647-200404000-00003
112. Hawkins, B. T., and Davis, T. P. (2005). The blood-brain bar-rier/neurovascular unit in health and disease. Pharmacol. Rev. 57, 173-185. doi: 10.1124/pr.57.2.4
113. Hawkins, B. T., Sykes, D. B., and Miller, D. S. (2010). Rapid, reversible modulation of blood-brain barrier p-glycoprotein transport activity by vascular endothelial growth factor. J. Neurosci. 30, 1417-1425. doi: 10.1523/JNEUROSCI.5103-09.2010
114. Hawkins, R. A., Peterson, D. R., and Vina, J. R. (2002). The complementary membranes forming the blood-brain barrier. IUBMB Life 54, 101-107. doi: 10.1080/15216540214541
115. Heinzer, S., Kuhn, G., Krucker, T., Meyer, E., Ulmann-Schuler, A., Stampanoni, M., et al. (2008). Novel three-dimensional analysis tool for vascular trees indicates complete micro-networks, not single capillaries, as the angiogenic endpoint in mice overexpressing human VEGF(165) in the brain. Neuroimage 39, 1549-1558. doi: 10.1016/j.neuroimage.2007.10.054
116. Hewitt, K. J., Agarwal, R., and Morin, P. J. (2006). The claudin gene family: expression in normal and neoplas-tic tissues. BMC Cancer 6:186. doi: 10.1186/1471-2407-6-186
117. Hirtz, D., Thurman, D. J., Gwinn-Hardy, K., Mohamed, M., Chaudhuri, A. R., and Zalutsky, R. (2007). How common are the common neurologic disorders? Neurology 68, 326-337. doi: 10. 1212/01.wnl.0000252807.38124.a3
118. Hobson, B., and Denekamp, J. (1984). Endothelial proliferation in tumours and normal tissues: continuous labelling studies. Br. J. Cancer 49, 405-413. doi: 10.1038/bjc.1984.66
119. Holliday, M. A. (1986). "Body composition and energy needs during growth," in Human Growth: A Comprehensive Treatise, eds F. Falkner and J. M. Tanner (Newyork, NY: Plenum), 101-117.
120. Hossmann, K. A. (2006). Pathophysiology and therapy of experimental stroke. Cell. Mol. Neurobiol. 26, 1057-1083. doi: 10.1007/s10571-006-9008-1
121. Hubatsch, I., Ragnarsson, E. G., and Artursson, P. (2007). Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers. Nat. Protoc. 2, 2111-2119. doi: 10.1038/nprot.2007.303
122. Iadecola, C. (2004). Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat. Rev. Neurosci. 5, 347-360. doi: 10.1038/nrn1387
123. Iadecola, C., and Nedergaard, M. (2007). Glial regulation of the cerebral microvasculature. Nat. Neurosci. 10, 1369-1376. doi: 10.1038/nn2003
124. Ito, H., Kanno, I., Ibaraki, M., Hatazawa, J., and Miura, S. (2003). Changes in human cerebral blood flow and cerebral blood volume during hypercapnia and hypocap-nia measured by positron emission tomography. J. Cereb. Blood Flow Metab. 23, 665-670. doi: 10.1097/ 01.WCB.0000067721.64998.F5
125. Ivey, N. S., Maclean, A. G., and Lackner, A. A. (2009). Acquired immunodeficiency syndrome and the blood-brain barrier. J. Neurovirol. 15, 111-122. doi: 10.1080/13550280902769764
126. Janzer, R. C., and Raff, M. C. (1987). Astrocytes induce blood brain barrier properties in endothelial cells. Nature 325, 253-257. doi: 10.1038/325253a0
127. Johnson, B. D., Mather, K. J., and Wallace, J. P. (2011). Mechanotransduction of shear in the endothelium: basic studies and clinical implications. Vasc. Med. 16, 365-377. doi: 10.1177/1358863X11422109
128. Kalaria, R. N. (1999). The blood-brain barrier and cerebrovascular pathology in Alzheimer's disease. Ann. N.Y. Acad. Sci. 893, 113-125. doi: 10.1111/j.1749-6632.1999.tb07821.x
129. Kamiya, A., Bukhari, R., and Togawa, T. (1984). Adaptive regulation of wall shear stress optimizing vascular tree function. Bull. Math. Biol. 46, 127-137.
130. Karbowski, J. (2007). Global and regional brain metabolic scaling and its functional consequences. BMC Biol. 5:18. doi: 10.1186/1741-7007-5-18
131. Karbowski, J. (2009). Thermodynamic constraints on neural dimensions, firing rates, brain temperature and size. J. Comput. Neurosci. 27, 415-436. doi: 10.1007/s10827-009-0153-7
132. Karbowski, J. (2011). Scaling of brain metabolism and blood flow in relation to capillary and neural scaling. PLoS ONE 6:e26709. doi: 10.1371/journal.pone.0026709
133. Karlsson, J., and Artursson, P. (1991). A method for the determination of cellular permeability coefficients and aqueous boundary-layer thickness in monolayers of intestinal epithelial (caco-2) cells grown in permeable filter chambers. Int. J. Pharm. 71, 55-64. doi: 10.1016/0378-5173(91)90067-X
134. Kedem, O., and Katchalsky, A. (1958). Thermodynamic analysis of the permeability of biological membranes to non-electrolytes. Biochim. Biophys. Acta 27, 229-246. doi: 10.1016/0006-3002(58)90330-5
135. Kermode, A. G., Thompson, A. J., Tofts, P., Macmanus, D. G., Kendall, B. E., Kingsley, D. P. E., et al. (1990). Breakdown of the blood-brain-barrier precedes symptoms and other mri signs of new lesions in multiple-sclerosis -pathogenetic and clinical implications. Brain 113, 1477-1489. doi: 10.1093/brain/113.5.1477
136. Kim, J. H., Kim, J. H., Yu, Y. S., Kim, D. H., and Kim, K. W. (2009). Recruitment of pericytes and astro-cytes is closely related to the formation of tight junction in developing retinal vessels. J. Neurosci. Res. 87, 653-659. doi: 10.1002/jnr.21884
137. Kim, J. V., and Dustin, M. L. (2006). Innate response to focal necrotic injury inside the blood-brain barrier. J. Immunol. 177, 5269-5277.
138. King, M., Su, W., Chang, A., Zuckerman, A., and Pasternak, G. W. (2001). Transport of opioids from the brain to the periphery by P-glycoprotein: peripheral actions of central drugs. Nat. Neurosci. 4, 268-274. doi: 10.1038/85115
139. Kinney, J. P., Spacek, J., Bartol, T. M., Bajaj, C. L., Harris, K. M., and Sejnowski, T. J. (2013). Extracellular sheets and tunnels modulate gluta-mate diffusion in hippocampal neu-ropil. J. Comp. Neurol. 521, 448-464. doi: 10.1002/cne.23181
140. Kleiber, M. (1947). Body size and metabolic rate. Physiol. Rev. 27, 511-541.
141. Klein, B., Kuschinsky, W., Schrock, H., and Vetterlein, F. (1986). Interdependency of local capillary density, blood-flow, and metabolism in rat brains. Am. J. Physiol. 251, H1333-H1340.
142. Kortekaas, R., Leenders, K. L., Van Oostrom, J. C., Vaalburg, W., Bart, J., Willemsen, A. T., et al. (2005). Blood-brain barrier dysfunction in parkinsonian midbrain in vivo. Ann. Neurol. 57, 176-179. doi: 10.1002/ana.20369
143. Koutsiaris, A. G., Tachmitzi, S. V., Batis, N., Kotoula, M. G., Karabatsas, C. H., Tsironi, E., et al. (2007). Volume flow and wall shear stress quantification in the human conjunc-tival capillaries and post-capillary venules in vivo. Biorheology 44, 375-386.
144. Krause, G., Winkler, L., Piehl, C., Blasig, I., Piontek, J., and Muller, S. L. (2009). Structure and function of extracellular claudin domains. Ann. N.Y. Acad. Sci. 1165, 34-43. doi: 10.1111/j.1749-6632.2009.04057.x
145. Kreczmanski, P., Heinsen, H., Mantua, V., Woltersdorf, F., Masson, T., Ulfig, N., et al. (2009). Microvessel length density, total length, and length per neuron in five subcortical regions in schizophrenia. Acta Neuropathol. 117, 409-421. doi: 10.1007/s00401-009-0482-7
146. Kreczmanski, P., Schmidt-Kastner, R., Heinsen, H., Steinbusch, H. W. M., Hof, P. R., and Schmitz, C. (2005). Stereological studies of capillary length density in the frontal cortex of schizophrenics. Acta Neuropathol. 109, 510-518. doi: 10.1007/s00401-005-1003-y
147. Krencik, R., Weick, J. P., Liu, Y., Zhang, Z. J., and Zhang, S. C. (2011). Specification of transplantable astroglial subtypes from human pluripotent stem cells. Nat. Biotechnol. 29, 528-534. doi: 10.1038/nbt.1877
148. Krizanac-Bengez, L., Mayberg, M. R., and Janigro, D. (2004). The cerebral vasculature as a therapeutic target for neurological disorders and the role of shear stress in vascular homeostatis and pathophysiol-ogy. Neurol. Res. 26, 846-853. doi: 10.1179/016164104X3789
149. Kroeger, D., Tamburri, A., Amzica, F., and Sik, A. (2010). Activity-dependent layer-specific changes in the extracellular chloride concentration and chloride driving force in the rat hippocampus. J. Neurophysiol. 103, 1905-1914. doi: 10.1152/jn.00497.2009
150. Krueger, M., and Bechmann, I. (2010). CNS pericytes: concepts, misconceptions, and a way out. Glia 58, 1-10. doi: 10.1002/glia.20898
151. Kubinyi, H. (1977). Quantitative structure-activity relationships. 7. The bilinear model, a new model for nonlinear dependence of biological activity on hydrophobic character. J. Med. Chem. 20, 625-629. doi: 10.1021/jm00215a002
152. Kuhnline Sloan, C. D., Nandi, P., Linz, T. H., Aldrich, J. V., Audus, K. L., and Lunte, S. M. (2012). Analytical and biological methods for probing the blood-brain barrier. Annu. Rev. Anal. Chem. (Palo Alto Calif) 5, 505-531. doi: 10.1146/annurev-anchem-062011-143002
153. Laurent, T. C., and Fraser, J. R. E. (1992). Hyaluronan. FASEB J. 6, 2397-2404.
154. Lee, G., Dallas, S., Hong, M., and Bendayan, R. (2001). Drug trans porters in the central nervous system: brain barriers and brain parenchyma considerations. Pharmacol. Rev. 53, 569-596.
155. Lee, S. W., Kim, W. J., Choi, Y. K., Song, H. S., Son, M. J., Gelman, I. H., et al. (2003). SSeCKS regulates angiogen-esis and tight junction formation in blood-brain barrier. Nat. Med. 9, 900-906. doi: 10.1038/nm889
156. Lennie, P. (2003). The cost of cortical computation. Curr. Biol. 13, 493-497. doi: 10.1016/S0960-9822(03)00135-0
157. Levesque, M. J., and Nerem, R. M. (1985). The elongation and orientation of cultured endothelial-cells in response to shear-stress. J. Biomech. Eng. 107, 341-347. doi: 10.1115/1.3138567
158. Liddelow, S. A. (2011). Fluids and barriers of the CNS: a historical viewpoint. Fluids Barriers CNS 8, 2. doi: 10.1186/2045-8118-8-2
159. Lipinski, C. A., Lombardo, F., Dominy, B. W., and Feeney, P. J. (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 46, 3-26. doi: 10.1016/S0169-409X(00)00129-0
160. Lippmann, E. S., Azarin, S. M., Kay, J. E., Nessler, R. A., Wilson, H. K., Al-Ahmad, A., et al. (2012). Derivation of blood-brain barrier endothelial cells from human pluripotent stem cells. Nat. Biotechnol. 30, 783-791. doi: 10.1038/nbt.2247
161. Lippoldt, A., Kniesel, U., Liebner, S., Kalbacher, H., Kirsch, T., Wolburg, H., et al. (2000). Structural alterations of tight junctions are associated with loss of polarity in stroke-prone spontaneously hypertensive rat blood-brain barrier endothelial cells. Brain Res. 885, 251-261. doi: 10.1016/S0006-8993(00)02954-1
162. Liu, X., Tu, M., Kelly, R. S., Chen, C., and Smith, B. J. (2004). Development of a computational approach to predict blood-brain barrier permeability. Drug Metab. Dispos. 32, 132-139. doi: 10.1124/dmd.32.1.132
163. Lo, E. H., Dalkara, T., and Moskowitz, M. A. (2003). Mechanisms, challenges and opportunities in stroke. Nat. Rev. Neurosci. 4, 399-415. doi: 10.1038/nrn1106
164. Madara, J. L. (1998). Regulation of the movement of solutes across tight junctions. Annu. Rev. Physiol. 60, 143-159. doi: 10.1146/annurev.physiol.60.1.143
165. Malek, A. M., and Izumo, S. (1996). Mechanism of endothelial cell shape change and cytoskele-tal remodeling in response to fluid shear stress. J. Cell Sci. 109, 713-726.
166. McNaught, A. D., and Wilkinson, A. (1997). Compendium of Chemical Terminology: IUPAC Recommendations. Oxford: Blackwell Science.
167. McQuaid, S., Cunnea, P., McMahon, J., and Fitzgerald, U. (2009). The effects of blood-brain barrier disruption on glial cell function in multiple sclerosis. Biochem. Soc. Trans. 37, 329-331. doi: 10.1042/BST0370329
168. Meyer, E. P., Ulmann-Schuler, A., Staufenbiel, M., and Krucker, T. (2008). Altered morphology and 3D architecture of brain vasculature in a mouse model for Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 105, 3587-3592. doi: 10.1073/pnas. 0709788105
169. Miller, D. S. (2003). Confocal imaging of xenobiotic transport across the blood-brain barrier. J. Exp. Zool. A Comp. Exp. Biol. 300A, 84-90. doi: 10.1002/jez.a.10313
170. Minagar, A., and Alexander, J. S. (2003). Blood-brain barrier disruption in multiple sclerosis. Mult. Scler. 9, 540-549. doi: 10.1191/1352458503ms965oa
171. Morita, K., Sasaki, H., Furuse, M., and Tsukita, S. (1999). Endothelial claudin: claudin-5/TMVCF constitutes tight junction strands in endothelial cells. J. Cell Biol. 147, 185-194. doi: 10.1083/jcb.147.1.185
172. Moskowitz, M. A., Lo, E. H., and Iadecola, C. (2010). The science of stroke: mechanisms in search of treatments. Neuron 67, 181-198. doi: 10.1016/j.neuron.2010.07.002
173. Nag, S. (2003). "Morphological and molecular properties of cellular components of normal cerebral vessels," in The Blood-Brain Barrier: Biological and Research Protocols, ed S. Nag (New Jersey, NJ: Humana Press), 3-36.
174. Nakagawa, S., Deli, M. A., Kawaguchi, H., Shimizudani, T., Shimono, T., Kittel, A., et al. (2009). A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes. Neurochem. Int. 54, 253-263. doi: 10.1016/j.neuint.2008.12.002
175. Navarrete, A., van Schaik, C. P., and Isler, K. (2011). Energetics and the evolution of human brain size. Nature 480, 91-93. doi: 10.1038/nature10629
176. Nerem, R. M., Levesque, M. J., and Cornhill, J. F. (1981). Vascular endothelial morphology as an indicator of the pattern of blood-flow. J. Biomech. Eng. 103, 172-176. doi: 10.1115/1.3138275
177. Neuwelt, E., Abbott, N., Abrey, L., Banks, W. A., Blakley, B., Davis, T., et al. (2008). Strategies to advance translational research into brain barriers. Lancet Neurol. 7, 84-96. doi: 10.1016/S1474-4422(07)70326-5
178. Neuwelt, E. A., Bauer, B., Fahlke, C., Fricker, G., Iadecola, C., Janigro, D., et al. (2011). Engaging neu-roscience to advance translational research in brain barrier biology. Nat. Rev. Neurosci. 12, 169-182. doi: 10.1038/nrn2995
179. Nicaise, C., Mitrecic, D., Demetter, P., De Decker, R., Authelet, M., Boom, A., et al. (2009). Impaired blood-brain and blood-spinal cord barriers in mutant SOD1-linked ALS rat. Brain Res. 1301, 152-162. doi: 10.1016/j.brainres.2009.09.018
180. Nicholson, C. (2001). Diffusion and related transport mechanisms in brain tissue. Rep. Prog. Phys. 64, 815-884. doi: 10.1088/0034-4885/64/7/202
181. Nitta, T., Hata, M., Gotoh, S., Seo, Y., Sasaki, H., Hashimoto, N., et al. (2003). Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J. Cell Biol. 161, 653-660. doi: 10.1083/jcb.200302070
182. Oberheim, N. A., Takano, T., Han, X., He, W., Lin, J. H. C., Wang, F., et al. (2009). Uniquely hominid features of adult human astrocytes. J. Neurosci. 29, 3276-3287. doi: 10.1523/JNEUROSCI.4707-08.2009
183. Oby, E., and Janigro, D. (2006). The blood-brain barrier and epilepsy. Epilepsia 47, 1761-1774. doi: 10.1111/j.1528-1167.2006.00817.x
184. Ohashi, T., and Sato, M. (2005). Remodeling of vascular endothe-lial cells exposed to fluid shear stress: experimental and numerical approach. Fluid Dyn. Res. 37, 40-59. doi: 10.1016/j.fluiddyn.2004.08.005
185. Ohno, K., Pettigrew, K. D., and Rapoport, S. I. (1978). Lower limits of cerebrovascular permeability to nonelectrolytes in the conscious rat. Am. J. Physiol. 235, H299-H307.
186. Ohtsuki, S., and Terasaki, T. (2007). Contribution of carrier-mediated transport systems to the blood-brain barrier as a supporting and protecting interface for the brain; importance for CNS drug discovery and development. Pharm. Res. 24, 1745-1758. doi: 10.1007/s11095-007-9374-5
187. Papadopoulos, M. C., Saadoun, S., Binder, D. K., Manley, G. T., Krishna, S., and Verkman, A. S. (2004). Molecular mechanisms of brain tumor edema. Neuroscience 129, 1011-1020. doi: 10.1016/j.neuroscience.2004.05.044
188. Papaioannou, T. G., and Stefanadis, C. (2005). Vascular wall shear stress: basic principles and methods. Hellenic J. Cardiol. 46, 9-15.
189. Pardridge, W. M. (1998). CNS drug design based on principles of blood-brain barrier transport. J. Neurochem. 70, 1781-1792. doi: 10.1046/j.1471-4159.1998.70051781.x
190. Pardridge, W. M. (2003). Blood-brain barrier drug targeting: the future of brain drug development. Mol. Interv. 3, 90-105. doi: 10.1124/mi.3.2.90
191. Pardridge, W. M. (2005). The blood-brain barrier: bottleneck in brain drug development. NeuroRx 2, 3-14. doi: 10.1602/neurorx.2.1.3
192. Pardridge, W. M. (2006). Molecular Trojan horses for blood-brain barrier drug delivery. Curr. Opin. Pharmacol. 6, 494-500. doi: 10.1016/j.coph.2006.06.001
193. Pardridge, W. M. (2008). Re-engineering biopharmaceuticals for delivery to brain with molecular Trojan horses. Bioconjug. Chem. 19, 1327-1338. doi: 10.1021/bc800148t
194. Pardridge, W. M. (2010). Biopharmaceutical drug targeting to the brain. J. Drug Target. 18, 157-167. doi: 10.3109/10611860903548354
195. Pardridge, W. M., Triguero, D., Yang, J., and Cancilla, P. A. (1990). Comparison of in vitro and in vivo models of drug transcytosis through the blood-brain barrier. J. Pharmacol. Exp. Ther. 253, 884-891.
196. Pathak, A. P., Kim, E., Zhang, J., and Jones, M. V. (2011). Three-dimensional imaging of the mouse neurovascula-ture with magnetic resonance microscopy. PLoS ONE 6:e22643. doi: 10.1371/journal.pone.0022643
197. Peppiatt, C. M., Howarth, C., Mobbs, P., and Attwell, D. (2006). Bidirectional control of CNS capillary diameter by peri-cytes. Nature 443, 700-704. doi: 10.1038/nature05193
198. Persidsky, Y., Heilman, D., Haorah, J., Zelivyanskaya, M., Persidsky, R., Weber, G. A., et al. (2006). Rho-mediated regulation of tight junctions during monocyte migration across the blood-brain barrier in HIV-1 encephalitis (HIVE). Blood 107, 4770-4780. doi: 10.1182/blood-2005-11-4721
199. Pike, V. W. (2009). PET radiotrac-ers: crossing the blood-brain barrier and surviving metabolism. Trends Pharmacol. Sci. 30, 431-440. doi: 10.1016/j.tips.2009.05.005
200. Piontek, J., Winkler, L., Wolburg, H., Muller, S. L., Zuleger, N., Piehl, C., et al. (2008). Formation of tight junction: determinants of homophilic interaction between classic claudins. FASEB J. 22, 146-158. doi: 10.1096/fj.07-8319com
201. Potts, R. (2011). Evolution big brains explained. Nature 480, 43-44. doi: 10.1038/480043a
202. Raichle, M. E., and Mintun, M. A. (2006). Brain work and brain imaging. Annu. Rev. Neurosci. 29, 449-476. doi: 10.1146/annurev. neuro.29.051605.112819
203. Rapoport, S. I., Ohno, K., and Pettigrew, K. D. (1979). Drug entry into the brain. Brain Res. 172, 354-359. doi: 10.1016/0006-8993(79)90546-8
204. Reese, T. S., and Karnovsky, M. J. (1967). Fine structural localization of a blood-brain barrier to exogenous peroxidase. J. Cell Biol. 34, 207-217. doi: 10.1083/jcb. 34.1.207
205. Reichel, A., Begley, D. J., and Abbottt, N. J. (2003). "An overview of in vitro techniques for blood brain barrier studies," in Methods in Molecular Medicine, Vol. 89: The Blood Brain Barrier, ed S. Nag (Totowa, NJ: Humana), 307-324. doi: 10.1385/1-59259-419-0:307
206. Remy, S., and Beck, H. (2006). Molecular and cellular mechanisms of pharmacoresistance in epilepsy. Brain 129, 18-35. doi: 10.1093/brain/awh682
207. Renkin, E. M. (1959). Transport of potassium-42 from blood to tissue in isolated mammalian skeletal muscles. Am. J. Physiol. 197, 1205-1210.
208. Ribatti, D., Nico, B., Crivellato, E., and Artico, M. (2006). Development of the blood-brain barrier: a historical point of view. Anat. Rec. B New Anat. 289, 3-8. doi: 10.1002/ar.b.20087
209. Robey, R. W., Honjo, Y., Van De Laar, A., Miyake, K., Regis, J. T., Litman, T., et al. (2001). A functional assay for detection of the mitox-antrone resistance protein, MXR (ABCG2). Biochim. Biophys. Acta 1512, 171-182. doi: 10.1016/S0005-2736(01)00308-X
210. Roth, G., and Dicke, U. (2005). Evolution of the brain and intelligence. Trends Cogn. Sci. (Regul. Ed.) 9, 250-257. doi: 10.1016/j.tics.2005.03.005
211. Sanes, J. R. (1989). Extracellular-matrix molecules that influence neural development. Annu. Rev. Neurosci. 12, 491-516. doi: 10.1146/ annurev.ne.12.030189.002423
212. Sawada, T., Kato, Y., Sakayori, N., Takekawa, Y., and Kobayashi, M. (1999). Expression of the multidrug-resistance P-glycoprotein (Pgp, MDR-1) by endothelial cells of the neovasculature in central nervous system tumors. Brain Tumor Pathol. 16, 23-27. doi: 10.1007/BF02478898
213. Schlageter, K. E., Molnar, P., Lapin, G. D., and Groothuis, D. R. (1999). Microvessel organization and structure in experimental brain tumors: microvessel populations with distinctive structural and functional properties. Microvasc. Res. 58, 312-328. doi: 10.1006/mvre.1999. 2188
214. Schramm, U., Fricker, G., Wenger, R., and Miller, D. S. (1995). P-glycoprotein-mediated secretion of a fluorescent cyclosporin analogue by teleost renal proximal tubules. Am. J. Physiol. 268, F46-F52.
215. Seiffert, E., Dreier, J. P., Ivens, S., Bechmann, I., Tomkins, O., Heinemann, U., et al. (2004). Lasting blood-brain barrier disruption induces epileptic focus in the rat somatosensory cortex. J. Neurosci. 24, 7829-7836. doi: 10.1523/JNEUROSCI.1751-04.2004
216. Shah, M. V., Audus, K. L., and Borchardt, R. T. (1989). The Application of bovine brain microvessel endothelial-cell mono-layers grown onto polycarbonate membranes in vitro to estimate the potential permeability of solutes through the blood-brain barrier. Pharm. Res. 6, 624-627. doi: 10.1023/A:1015913817221
217. Shen, L., Weber, C. R., Raleigh, D. R., Yu, D., and Turner, J. R. (2011). Tight junction pore and leak pathways: a dynamic duo. Annu. Rev. Physiol. 73, 283-309. doi: 10.1146/annurev-physiol-012110-142150
218. Shepro, D., and Morel, N. M. (1993). Pericyte physiology. FASEB J. 7, 1031-1038.
219. Shlosberg, D., Benifla, M., Kaufer, D., and Friedman, A. (2010). Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury. Nat. Rev. Neurol. 6, 393-403. doi: 10.1038/nrneurol. 2010.74
220. Shulman, R. G., Rothman, D. L., Behar, K. L., and Hyder, F. (2004). Energetic basis of brain activity: implications for neuroimaging. Tre n ds Neu rosc i. 27, 489-495. doi: 10.1016/j.tins.2004.06.005
221. Siakotos, A. N., Rouser, G., and Fleischer, S. (1969). Isolation of highly purified human and bovine brain endothelial cells and nuclei and their phospholipid composition. Lipids 4, 234-239. doi: 10.1007/BF02532638
222. Siddharthan, V., Kim, Y. V., Liu, S., and Kim, K. S. (2007). Human astrocytes/astrocyte- conditioned medium and shear stress enhance the barrier properties of human brain microvascular endothelial cells. Brain Res. 1147, 39-50. doi: 10.1016/j.brainres. 2007.02.029
223. Siflinger-Birnboim, A., Delvecchio, P. J., Cooper, J. A., Blumenstock, F. A., Shepard, J. M., and Malik, A. B. (1987). Molecular-sieving characteristics of the cultured endothelial monolayer. J. Cell. Physiol. 132, 111-117. doi: 10.1002/jcp.1041320115
224. Sims, D. E. (1986). The pericyte - a review. Tissue Cell 18, 153-174. doi: 10.1016/0040-8166(86)90026-1
225. Sloan, C. D. K., Nandi, P., Linz, T. H., Aldrich, J. V., Audus, K. L., and Lunte, S. M. (2012). "Analytical and biological methods for probing the blood-brain barrier," in Annual Review of Analytical Chemistry, Vol. 5, eds R. G. Cooks and E. S. Yeung (Palo Alto, CA: Annual Reviews), 505-531.
226. Smith, Q. R. (2003). "A review of blood-brain barrier transport techniques," in The Blood-Brain Barrier: Biology and Research Protocols, ed S. Nag (Totowa, NJ: Humana Press), 193-208.
227. Smith, Q. R., and Allen, D. D. (2003). "In situ brain perfusion technique," in The Blood-Brain Barrier: Biology and Research Protocols, ed. S. Nag (Totowa, NJ: Humana Press), 209-218.
228. Smith, Q. R., and Takasato, Y. (1986). Kinetics of amino acid transport at the blood-brain barrier studied using an in situ brain perfu-sion technique. Ann. N.Y. Acad. Sci. 481, 186-201. doi: 10.1111/j.1749-6632.1986.tb27150.x
229. Snodgrass, J. J., Leonard, W. R., and Robertson, M. L. (2009). The energetics of encephalization in early hominids. Evol. Hominin Diets 15-29. doi: 10.1007/978-1-4020-9699-0_2
230. Sohet, F., and Daneman, R. (2013). Genetic mouse models to study blood-brain barrier development and function. Fluids Barriers CNS 10, 3. doi: 10.1186/2045-8118-10-3
231. Stahel, P. F., Shohami, E., Younis, F. M., Kariya, K., Otto, V. I., Lenzlinger, P. M., et al. (2000). Experimental closed head injury: analysis of neurological outcome, blood-brain barrier dysfunction, intracranial neutrophil infiltration, and neuronal cell death in mice deficient in genes for pro-inflammatory cytokines. J. Cereb. Blood Flow Metab. 20, 369-380. doi: 10.1097/00004647-200002000-00019
232. Stenberg, P., Norinder, U., Luthman, K., and Artursson, P. (2001). Experimental and computational screening models for the prediction of intestinal drug absorption. J. Med. Chem. 44, 1927-1937. doi: 10.1021/jm001101a
233. Stins, M. F., Gilles, F., and Kim, K. S. (1997). Selective expression of adhesion molecules on human brain microvascular endothe-lial cells. J. Neuroimmunol. 76, 81-90. doi: 10.1016/S0165-5728 (97)00036-2
234. Summerfield, S. G., Read, K., Begley, D. J., Obradovic, T., Hidalgo, I. J., Coggon, S., et al. (2007). Central nervous system drug disposition: the relationship between in situ brain permeability and brain free fraction. J. Pharmacol. Exp. Ther. 322, 205-213. doi: 10.1124/jpet.107.121525
235. Summerfield, S. G., Stevens, A. J., Cutler, L., Del Carmen Osuna, M., Hammond, B., Tang, S.-P., et al. (2006). Improving the in vitro prediction of in vivo central nervous system penetration: integrating permeability, p-glycoprotein efflux, and free fractions in blood and brain. J. Pharmacol. Exp. Ther. 316, 1282-1290. doi: 10.1124/jpet.105.092916
236. Sykova, E., and Nicholson, C. (2008). Diffusion in brain extracellular space. Physiol. Rev. 88, 1277-1340. doi: 10.1152/physrev. 00027.2007
237. Taddei, A., Giampietro, C., Conti, A., Orsenigo, F., Breviario, F., Pirazzoli, V., et al. (2008). Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5. Nat. Cell Biol. 10, 923-934. doi: 10.1038/ncb1752
238. Takano, T., Tian, G. F., Peng, W., Lou, N., Libionka, W., Han, X., et al. (2006). Astrocyte-mediated control of cerebral blood flow. Nat. Neurosci. 9, 260-267. doi: 10.1038/nn1623
239. Takasato, Y., Rapoport, S. I., and Smith, Q. R. (1984). An in situ brain perfu-sion technique to study cerebrovas-cular transport in the rat. Am. J. Physiol. 247, H484-H493.
240. Tarbell, J. M. (2010). Shear stress and the endothelial transport barrier. Cardiovasc. Res. 87, 320-330. doi: 10.1093/cvr/cvq146
241. Tewes, B. J., and Galla, H. J. (2001). Lipid polarity in brain capillary endothelial cells. Endothelium 8, 207-220. doi: 10.3109/10623320109051566
242. Thanabalasundaram, G., Schneidewind, J., Pieper, C., and Galla, H. J. (2011). The impact of pericytes on the blood-brain barrier integrity depends critically on the pericyte differentiation stage. Int. J. Biochem. Cell Biol. 43, 1284-1293. doi: 10.1016/j.biocel. 2011.05.002
243. Thorne, R. G., Hrabetova, S., and Nicholson, C. (2005). Diffusion measurements for drug design. Nat. Mater. 4, 713-713. doi: 10.1038/nmat1489
244. Thorne, R. G., and Nicholson, C. (2006). In vivo diffusion analysis with quantum dots and dextrans predicts the width of brain extracellular space. Proc. Natl. Acad. Sci. U.S.A. 103, 5567-5572. doi: 10.1073/pnas.0509425103
245. Tilling, T., Engelbertz, C., Decker, S., Korte, D., Huwel, S., and Galla, H. J. (2002). Expression and adhesive properties of basement membrane proteins in cerebral capillary endothelial cell cultures. Cell Tissue Res. 310, 19-29. doi: 10.1007/s00441-002-0604-1
246. Tilling, T., Korte, D., Hoheisel, D., and Galla, H. J. (1998). Basement membrane proteins influence brain capillary endothelial barrier function in vitro. J. Neurochem. 71, 1151-1157. doi: 10.1046/j.1471-4159.1998.71031151.x
247. Toole, B. P. (2004). Hyaluronan: from extracellular glue to pericellular cue. Nat. Rev. Cancer 4, 528-539. doi: 10.1038/nrc1391
248. Tran, T. T., Mittal, A., Gales, T., Maleeff, B., Aldinger, T., Polli, J. W., et al. (2004). Exact kinetic analysis of passive transport across a polarized confluent MDCK cell mono-layer modeled as a single barrier. J. Pharm. Sci. 93, 2108-2123. doi: 10.1002/jps.20105
249. Tsukita, S., and Furuse, M. (1999). Occludin and claudins in tight-junction strands: leading or supporting players? Tre n ds Ce ll B iol. 9, 268-273. doi: 10.1016/S0962-8924(99)01578-0
250. Tsukita, S., Furuse, M., and Itoh, M. (2001). Multifunctional strands in tight junctions. Nat. Rev. Mol. Cell Biol. 2, 285-293. doi: 10.1038/35067088
251. Tunblad, K., Jonsson, E. N., and Hammarlund-Udenaes, M. (2003). Morphine blood-brain barrier transport is influenced by probenecid co-administration. Pharm. Res. 20, 618-623. doi: 10.1023/A:1023250900462
252. Turitto, V. T. (1982). Blood viscosity, mass transport, and thrombo-genesis. Prog. Hemost. Thromb. 6, 139-177.
253. Turley, E. A., Noble, P. W., and Bourguignon, L. Y. (2002). Signaling properties of hyaluronan receptors. J. Biol. Chem. 277, 4589-4592. doi: 10.1074/jbc.R100038200
254. Uchiyama, S., Carlin, A. F., Khosravi, A., Weiman, S., Banerjee, A., Quach, D., et al. (2009). The surface-anchored NanA protein promotes pneumococcal brain endothelial cell invasion. J. Exp. Med. 206, 1845-1852. doi: 10.1084/jem.20090386
255. Ueno, M. (2009). Mechanisms of the penetration of blood-borne substances into the brain. Curr. Neuropharmacol. 7, 142-149. doi: 10.2174/157015909788848901
256. Ullian, E. M., Sapperstein, S. K., Christopherson, K. S., and Barres, B. A. (2001). Control of synapse number by glia. Science 291, 657-661. doi: 10.1126/science.291. 5504.657
257. Ungerstedt, U. (1991). Microdialysis- principles and applications for studies in animals and man. J. Intern. Med. 230, 365-373. doi: 10.1111/j.1365-2796.1991.tb00459.x
258. Volterra, A., and Meldolesi, J. (2005). Astrocytes, from brain glue to communication elements: the revolution continues. Nat. Rev. Neurosci. 6, 626-640. doi: 10.1038/nrn1722
259. Wang, X., Sykes, D. B., and Miller, D. S. (2010). Constitutive androstane receptor-mediated up-regulation of atp-driven xenobiotic efflux transporters at the blood-brain barrier. Mol. Pharmacol. 78, 376-383. doi: 10.1124/mol.110.063685
260. Waterhouse, R. N. (2003). Determination of lipophilicity and its use as a predictor of blood-brain barrier penetration of molecular imaging agents. Mol. Imaging Biol. 5, 376-389. doi: 10.1016/j.mibio.2003.09.014
261. Waubant, E. (2006). Biomarkers indicative of blood-brain barrier disruption in multiple sclerosis. Dis. Markers 22, 235-244. doi: 10.1155/2006/709869
262. Wen, H., Watry, D. D., Marcondes, M. C., and Fox, H. S. (2004). Selective decrease in para- cellular conductance of tight junctions: role of the first extra cellular domain of claudin-5. Mol. Cell. Biol. 24, 8408-8417. doi: 10.1128/MCB.24.19.8408-8417.2004
263. Wils, P., Warnery, A., Phungba, V., Legrain, S., and Scherman, D. (1994). High lipophilicity decreases drug transport across intestinal epithelial-cells. J. Pharmacol. Exp. Ther. 269, 654-658.
264. Winkler, E. A., Bell, R. D., and Zlokovic, B. V. (2011). Central nervous system pericytes in health and disease. Nat. Neurosci. 14, 1398-1405. doi: 10.1038/nn.2946
265. Wolburg, H., and Lippoldt, A. (2002). Tight junctions of the blood-brain barrier: development, composition and regulation. Vascul. Pharmacol. 38, 323-337. doi: 10.1016/S1537-1891(02)00200-8
266. Yamaguchi, Y. (2000). Lecticans: organizers of the brain extracellular matrix. Cell. Mol. Life Sci. 57, 276-289. doi: 10.1007/PL00000690
267. Yee, S. Y. (1997). In vitro permeability across Caco2 cells (colonic) can predict in vivo (small intestinal) absorption in man - Fact or myth. Pharm. Res. 14, 763-766. doi: 10.1023/A:1012102522787
268. Youdim, K. A., Avdeef, A., and Abbott, N. J. (2003). In vitro trans-monolayer permeability calculations: often forgotten assumptions. Drug Discov. Today 8, 997-1003. doi: 10.1016/S1359-6446 (03)02873-3
269. Youdim, K. A., Qaiser, M. Z., Begley, D. J., Rice-Evans, C. A., and Abbott, N. J. (2004). Flavonoid permeability across an in situ model of the blood-brain barrier. Free Radic. Biol. Med. 36, 592-604. doi: 10.1016/j. freeradbiomed.2003.11.023
270. Zhao, R., Kalvass, J. C., and Pollack, G. M. (2009). Assessment of blood-brain barrier permeability using the in situ mouse brain perfu-sion technique. Pharm. Res. 26, 1657-1664. doi: 10.1007/s11095-009-9876-4
271. Zhong, Z., Deane, R., Ali, Z., Parisi, M., Shapovalov, Y., O'banion, M. K., et al. (2008). ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration. Nat. Neurosci. 11, 420-422. doi: 10.1038/nn2073
272. Zhu, X. H., Qiao, H. Y., Du, F., Xiong, Q., Liu, X., Zhang, X. L., et al. (2012). Quantitative imaging of energy expenditure in human brain. Neuroimage 60, 2107-2117. doi: 10.1016/j.neuro image.2012.02.013
273. Zimmermann, D. R., and Dours-Zimmermann, M. T. (2008). Extracellular matrix of the central nervous system: from neglect to challenge. Histochem. Cell Biol. 130, 635-653. doi: 10.1007/s00418-008-0485-9
274. Zipser, B. D., Johanson, C. E., Gonzalez, L., Berzin, T. M., Tavares, R., Hulette, C. M., et al. (2007). Microvascular injury and blood-brain barrier leakage in Alzheimer's disease. Neurobiol. Aging 28, 977-986. doi: 10.1016/j.neuro biolaging.2006.05.016
275. Zlokovic, B. V. (2005). Neurovascular mechanisms of Alzheimer's neurodegeneration. Trends Neurosci. 28, 202-208. doi: 10.1016/j.tins.2005.02.001
276. Zonta, M., Angulo, M. C., Gobbo, S., Rosengarten, B., Hossmann, K. A., Pozzan, T., et al. (2003). Neuron-to-astrocyte signaling is central to the dynamic control of brain microcirculation. Nat. Neurosci. 6, 43-50. doi: 10.1038/nn980